SCHEMBL6136786

SCHEMBL6136786

CCOC(=O)C(F)(C(=O)OCC)c1cccs1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 2/20 0.42
GAA P10253 2/20 0.42
LMNA P02545 1/20 0.42
HTT P42858 1/20 0.42
POLB P06746 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TSHR P16473 2/20 0.41
PIN1 Q13526 1/20 0.41
CHRM2 P08172 1/20 0.40
CHRM4 P08173 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MAPT P10636 2/20 0.39
KEAP1 Q14145 1/20 0.39
HDAC3 O15379 2/20 0.39
HDAC1 Q13547 2/20 0.39
HDAC4 P56524 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27575627 0.87 TSHR (0.44) ALDH1A1KDM4EGAALMNAHTT
SCHEMBL13069739 0.83 TSHR (0.48) KDM4ELMNAHTTPOLBNPSR1
SCHEMBL1456077 0.82 ALDH1A1 (0.43) ALDH1A1KDM4EGAALMNAHTT
SCHEMBL2989486 0.82 TSHR (0.42) ALDH1A1KDM4EGAALMNAHTT
SCHEMBL7450936 0.82 TSHR (0.42) ALDH1A1KDM4EGAALMNAHTT
SCHEMBL2289504 0.82 CHRM3 (0.46) ALDH1A1KDM4EGAAPOLBTSHR
SCHEMBL2997460 0.81 ESR1 (0.46) ALDH1A1KDM4EGAALMNAHTT
SCHEMBL2130216 0.81 PIN1 (0.44) ALDH1A1KDM4EGAALMNAHTT
SCHEMBL11024141 0.81 TSHR (0.41) ALDH1A1KDM4EGAAPOLBNPSR1
SCHEMBL10335551 0.79 CHRM3 (0.47) ALDH1A1KDM4EGAATSHRPIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1337218-A4 SUBSTITUTED FELBAMATE DERIVED COMPOUNDS UNIV VIRGINIA (US) 2005-08-10 EP disclosed
US-20040023986-A1 Substituted felbamate derived compounds GENERAL ELECTRIC CAPITAL CORPORATION 2004-02-05 US disclosed
EP-1337218-A2 SUBSTITUTED FELBAMATE DERIVED COMPOUNDS UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2003-08-27 EP disclosed
WO-2002056827-A2 SUBSTITUTED FELBAMATE DERIVED COMPOUNDS UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2002-07-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040023986-A1 Substituted felbamate derived compounds CACNA1B, GABRB1, GABRB3 ALDH1A1 485/4885KDM4E 1697/4885GAA 677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.